Scopeora News & Life

© 2026 Scopeora News & Life

Synthetic Biology

Colossal Biosciences Eyes Major New Funding at Up to $30 Billion Valuation

Colossal Biosciences Eyes Major New Funding at Up to $30 Billion Valuation

Colossal Biosciences is reportedly seeking new funding at a $20B-$30B valuation as its de-extinction science, spinouts, and revenue model gain momentu...

Innovative Bacteria Engineered to Target Cancer Tumors from Within
Science
Innovative Bacteria Engineered to Target Cancer Tumors from Within

University of Waterloo researchers are pioneering a method that uses engineered bacteria to target and eliminate cancer...